Krista Meinert, BA, NMIT
Long before psilocybin became the subject of modern research, clinical trials, and conversations about psychedelic-assisted care, humans were engaging with psilocybin-containing mushrooms as part of spiritual, ceremonial, and healing traditions.
The history of psilocybin is not simply the history of a chemical compound. It is also a story about Indigenous knowledge, cultural traditions, scientific discovery, prohibition, and a growing modern effort to understand psychedelics through both research and lived experience.
Psilocybin-containing mushrooms have a long history of ceremonial use among Indigenous peoples of Mesoamerica. Archaeological evidence, including distinctive mushroom-shaped artifacts sometimes referred to as “mushroom stones,” has been interpreted as evidence of an ancient relationship with sacred mushrooms, although their exact purpose and meaning remain debated.
Among some Indigenous communities, mushrooms containing psilocybin were used within carefully held ceremonial and spiritual contexts. The mushrooms were understood not simply as recreational substances, but as tools connected with healing, divination, community, and relationships with the spiritual world.
The Spanish arrival in the Americas brought profound disruption to these traditions. Colonial authorities and missionaries often viewed Indigenous mushroom ceremonies as incompatible with Christianity and attempted to suppress their use.
Despite this pressure, knowledge and ceremonial practices survived within some communities.
One of the earliest widely recognized written European accounts of ceremonial mushroom use came from Spanish Franciscan friar Bernardino de Sahagún in the 16th century. His writings described Indigenous use of psychoactive mushrooms in what is now Mexico.
For centuries afterward, much of this knowledge remained largely outside Western scientific awareness.
That began to change in the 20th century.
In the 1950s, the Mazatec healer María Sabina became an important figure in bringing Western attention to the ceremonial use of psilocybin mushrooms.
In 1955, amateur mycologist R. Gordon Wasson participated in a Mazatec mushroom ceremony with María Sabina in Huautla de Jiménez, Mexico. He later wrote about the experience for Life magazine in an article published in 1957.
The article introduced millions of Americans to the existence of sacred mushroom ceremonies.
For María Sabina and her community, however, this attention came at a significant cost. Increased interest from outsiders brought tourists and unwanted attention to the community, and her family and community experienced serious consequences.
Her story is an important reminder that the modern psychedelic movement did not discover these mushrooms. Indigenous peoples had maintained relationships with them for generations.
Scientific interest accelerated in the late 1950s.
Swiss chemist Albert Hofmann, who had previously synthesized LSD, isolated and identified the psychoactive compounds psilocybin and psilocin from Psilocybe mushrooms in 1957.
The discovery gave researchers a way to study the effects of the mushrooms using a defined chemical compound rather than an entire mushroom.
During the 1950s and 1960s, researchers began investigating psychedelics for their potential applications in psychology, psychiatry, spirituality, and human consciousness.
The 1960s became a defining period in psychedelic history.
Researchers at universities and medical institutions investigated substances including psilocybin and LSD. Early studies explored questions involving perception, personality, spirituality, creativity, addiction, and psychological distress.
Among the researchers who became particularly influential was Timothy Leary, who conducted psilocybin research at Harvard before becoming one of the most recognizable public advocates of psychedelics.
The growing cultural association between psychedelics and the counterculture, however, contributed to increasing political and public opposition.
In the United States, the Controlled Substances Act of 1970 placed psilocybin into Schedule I, a category defined under federal law as having high abuse potential, no currently accepted medical use, and insufficient accepted safety for use under medical supervision.
The political and cultural climate surrounding psychedelics made scientific research increasingly difficult.
For decades, legitimate psychedelic research became extremely limited.
The pause in research did not mean that interest disappeared. Researchers, clinicians, Indigenous communities, therapists, advocates, and people with personal experience continued to explore questions surrounding psychedelics.
Beginning in the 1990s and accelerating through the 2000s and 2010s, scientific interest in psychedelics began to re-emerge.
Universities and research institutions started conducting controlled studies examining psilocybin’s effects on areas including depression, anxiety associated with serious illness, substance use disorders, and other psychological conditions.
Modern research has been particularly interested in how psilocybin may temporarily alter patterns of brain activity, perception, emotional processing, and the sense of self.
Importantly, contemporary research is not simply returning to the 1960s. Researchers are approaching psilocybin with modern clinical standards, carefully controlled environments, screening procedures, informed consent, preparation, monitoring, and integration.
Colorado and Oregon became an important part of this modern history.
In 2022, Colorado voters approved Proposition 122, establishing a legal framework for the regulated access and supervised use of certain natural medicines, including psilocybin, under Colorado law.
The state subsequently developed a regulated natural medicine system designed to establish standards around natural medicine services, facilitator training, preparation, administration sessions, and integration.
This represents a significant shift in the relationship between psychedelics and public policy.
At the same time, Colorado’s framework exists within a complicated national landscape. Psilocybin remains federally controlled in the United States, meaning state-level regulation does not make psilocybin federally legal.
As modern psychedelic work continues to evolve, it is important to remember that the current conversation did not begin in a laboratory.
Indigenous communities carried knowledge of sacred mushrooms long before Western science identified psilocybin and psilocin. Their traditions, languages, ceremonies, and relationships with these medicines deserve acknowledgment and respect.
The modern psychedelic field has an opportunity to learn from both scientific research and the cultural histories that preceded it, without treating Indigenous traditions as simply a historical footnote or claiming to have discovered something that was already deeply known.
Today, psilocybin sits at an unusual intersection of ancient tradition, modern science, personal exploration, and evolving public policy.
Its history includes sacred ceremony, colonial suppression, scientific discovery, cultural upheaval, decades of prohibition, and a remarkable return to scientific investigation.
Understanding that history helps place today’s work in perspective.
Psilocybin is not a new discovery.
The modern conversation about it is.
This history informs a philosophy grounded in respect, preparation, informed choice, presence, and integration, recognizing both the scientific research emerging today and the Indigenous traditions that came long before it.
Loading...